Clinical trial
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
NCT00002478 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00002478 |
|---|---|
| Title | Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer |
| Official title | Phase II Study of Prolonged Oral VP-16 for Advanced Ovarian Epithelial and Cervical Cancer |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Ovarian Cancer |
| Intervention type | Drug |
| Interventions | etoposide |
| Start date | Jun 1, 1993 |
| Primary completion | Oct 1, 2003 |
| First posted | Jun 9, 2004 |
| Last update posted | Jun 10, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: